Found 90 matching trials
Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population PHASE3 The primary objective is to assess the systemic and local safety profile of...
Show More Location
Research Institute for Tropical Medicine
Learn More & Join Trial
Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas PHASE4 This study aims to assess the neutralizing antibody levels and prevalence r...
Show More Status
Active Not Recruiting
Location
Liaoning Provincial Center for Disease Control and Prevention
Learn More & Join Trial
Purified Inactivated Japanese Encephalitis Vaccine PHASE3 This study evaluates the immunogenicity and safety of a purified inactivate...
Show More Location
Disease prevention and control center of Inner Mongolia autonomous region
Learn More & Join Trial
Immunogenicity of SA 14-14-2 JE Vaccine PHASE4 The proposed Japanese Encephalitis (JE)Vaccine study is a four-arm double-b...
Show More Learn More & Join Trial
Predicting Functional Outcome and Response to Therapy of Anti-NMDAR Encephalitis at Diagnosis N/A The goal of this international cohort study is to develop a prediction mode...
Show More Location
Erasmus Medical Center
Learn More & Join Trial
Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and Children PHASE2 Safety:
To describe the safety profiles following vaccination.
Immunogeni...
Show More Location
Multiple Locations
Learn More & Join Trial
Evalution of Immunogenicity, Safety and Booster Response of a Rabies Vaccine Administered Concomitantly With Japanese Encephalitis Vaccine in Toddlers PHASE2 This study evaluated the safety and immunogenicity of rabies vaccine and Ja...
Show More Location
Tropical Medicine, Mahidol University
Learn More & Join Trial
Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX PHASE4 This study was undertaken to assess the immunogenicity and safety of a boos...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults PHASE1 This is a 2-Stage, Phase I/II Study to Assess the Safety, Reactogenicity, a...
Show More Location
Nucleus Network - Brisbane (Q Pharm)
Learn More & Join Trial
Post-licensure Safety Study of IMOJEV® in Thailand PHASE4 The aim of this study is to further characterize the safety profile of IMOJ...
Show More Location
Multiple Locations
Learn More & Join Trial